TickerFactsScreenerDevelopers

Syndax Pharmaceuticals Inc (SNDX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$35.16M2017: -$47.37M2018: -$68.53M2019: -$50.61M2020: -$71.26M2021: $29.13M2022: -$133.68M2023: -$160.60M2024: -$274.90M2025: -$322.98M-$322.98M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$322.98M-17.5%
2024-$274.90M-71.2%
2023-$160.60M-20.1%
2022-$133.68M-558.9%
2021$29.13M+140.9%
2020-$71.26M-40.8%
2019-$50.61M+26.1%
2018-$68.53M-44.7%
2017-$47.37M-34.7%
2016-$35.16M—